Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Adrenergic agents for BPH described by Abbott in patent literature

Sep. 15, 1998

New agent for unstable bladder introduced in U.K.

Sep. 11, 1998

WAY-140288: a follow-up V2 antagonist and aquaretic agent from Wyeth-Ayerst

Aug. 28, 1998

Profile of VPA-985, Wyeth-Ayerst's aquaretic agent in clinical trials

Aug. 28, 1998

A-131701: a uroselective alpha-adrenergic agent for treatment of BPH

Aug. 27, 1998

GG-745: a 5alpha-reductase inhibitor with significant advantages over finasteride

Aug. 27, 1998

Antimuscarinic agent KRP-197 shows potential for treating incontinence

Aug. 24, 1998

HMR-4902 protects against acute renal failure in rats

Aug. 20, 1998

Kissei studies beta-adrenergic drug for use in patients with urolithiasis

Aug. 18, 1998

New compound for urinary incontinence poised to enter clinical testing at Recordati

Aug. 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...